Screening modestly reduces prostate cancer deaths
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from… read more.
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from… read more.
Krystal Biotech announced that, on May 15, 2026, the United Kingdom MHRA granted marketing authorization to Vyjuvek (beremagene geperpavec-svdt) for the treatment of wounds in patients with dystrophic epidermolysis… read more.
A research team co-led by investigators at Mass General Brigham and the Broad Institute of MIT and Harvard has developed and validated an artificial intelligence model, known as ECG2Stroke, that… read more.
It is quite possible that in the near future, people will have to describe their symptoms to an AI before they can get a doctor’s appointment. The AI… read more.
The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today’s artificial intelligence (AI) techniques now go far beyond mere automation: they make it possible… read more.
The Nuffield Department of Women’s & Reproductive Health at the University of Oxford, together with Serac Healthcare Limited announces the publication of Phase 2 data in The Lancet Obstetrics and Gynaecology. The findings highlight the… read more.
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionally impacts people who receive care in under-resourced settings. Fortunately, several… read more.
People who have experienced childhood sexual abuse have twice the odds of receiving a cancer diagnosis at age 65 or older compared to others who have not experienced… read more.
Royal Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Rembra platform of scanning systems, including Rembra CT, Rembra RT and Areta RT…. read more.
Denali Therapeutics Inc. announced the FDA has granted accelerated approval for Avlayah (tividenofusp alfa-eknm), the first FDA-approved biologic specifically designed to cross the blood-brain barrier and reach the… read more.
A new blood test, using a marker for late-stage Alzheimer’s disease, could offer a clinically relevant dementia diagnosis with fewer false positives, according to researchers at Lund University… read more.
A collaboration between Karolinska Institutet, Karolinska University Hospital, and SciLifeLab has integrated whole genome sequencing into routine diagnostic investigations for rare diseases at Karolinska University Hospital. To date,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.